Sequana Medical announces Extraordinary General Meeting of Shareholders on 10 November 2023

2 years ago

PRESS RELEASEREGULATED INFORMATION06 October 2023, 07:00 am CEST   Ghent, Belgium – 06 October 2023 – Sequana Medical NV (Euronext…

Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO

2 years ago

VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0)…

Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023

2 years ago

SAN FRANCISCO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a…

Athira Pharma Presents Preclinical Data Further Supporting the Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)

2 years ago

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated by consistent reduction in plasma…

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

2 years ago

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

2 years ago

                  Monthly information regarding the total number of voting rights and total number…

Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics

2 years ago

UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three…

AMN Healthcare to Hold Third Quarter 2023 Earnings Conference Call on Thursday, November 2, 2023

2 years ago

DALLAS, Oct. 05, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss…

Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

2 years ago

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA) (the “Company” or “Kineta”), a clinical-stage biotechnology company focused…

ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons

2 years ago

Financial visibility extended to Q1 2025 without drawing on the equity-linked financing facilityTOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX…